Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Single-cell transcriptome profiling of tumour tissue isolates allows the characterization of heterogeneous tumour cells along with neighbouring stromal and immune cells. Here we adopt this powerful approach to breast cancer and analyse 515 cells from 11 patients. Inferred copy number variations from the single-cell RNA-seq data separate carcinoma cells from non-cancer cells. At a single-cell resolution, carcinoma cells display common signatures within the tumour as well as intratumoral heterogeneity regarding breast cancer subtype and crucial cancer-related pathways. Most of the non-cancer cells are immune cells, with three distinct clusters of T lymphocytes, B lymphocytes and macrophages. T lymphocytes and macrophages both display immunosuppressive characteristics: T cells with a regulatory or an exhausted phenotype and macrophages with an M2 phenotype. These results illustrate that the breast cancer transcriptome has a wide range of intratumoral heterogeneity, which is shaped by the tumour cells and immune cells in the surrounding microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Limited T-cell recruitment and function in the TME correlates with poor prognosis in BC (21,22).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · cited 1×
“4.0b (default parameters) 55 , and relative gene expression was quantified as transcript per million (TPM) using RSEM v1.”
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · cited 1×
“To assess gene expression signatures and pathway activation, a non-parametric and unsupervised software algorithm called GSVA software in the R package 58 with the RNA-seq mode was used.”
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · cited 1×
“To further delineate the identity of carcinoma and non-carcinoma cells, we analysed the expression of tumour-associated stromal or immune gene sets proposed in the tumour purity estimation, ESTIMATE 26 .”
Cited by
Items 801–900 of 999
Li, R., Chen, X., Huang, Q., Ling, H.-J., Gong, K., & Chen, Z. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218753 · Cited by 3
Liu, Y., Cao, W., Jin, Y., & Xu, W. (2026) · PLoS ONE · doi:10.1371/journal.pone.0354524 · Cited by 1
“Comprehensive exploration of the functional significance of NK cells in breast cancer is incomplete, potentially due to low NK cell infiltration within tumors [17,27,30], the diversity of functional NK cell subtypes [29,31], and heterogeneity among breast cancer patients [47–49].”
Smail, H. O. (2022) · Biology Medicine & Natural Product Chemistry · doi:10.14421/biomedich.2022.111.45-54 · Cited by 1
“Gene expression-based molecular subtyping has also been broadly applied to breast cancer to aid treatment decisions (Chung et al., 2017).”
BackgroundTransforming Diagnosis and Therapeutics Using Cancer Genomics
Mehmood, S., Aslam, S., Dilshad, E., Ismail, H., & Khan, A. N. (2023) · Cancer treatment and research · doi:10.1007/978-3-031-27156-4_2 · Cited by 1
Hyperbolic Feature Fusion for Single-cell RNA-seq Classification
Li, J., Liu, C., Wang, J., & Chen, J. (2023) · International Conference on Intelligent Computing and Signal Processing (ICSP) · doi:10.1109/icsp58490.2023.10248703 · Cited by 1
Liu, F., Liu, X., Liu, Y., Chen, D., Liu, X., Qin, C., Song, Y., Fang, H., & Wu, D. (2024) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09850-z · Cited by 2
“The characterization of tumor heterogeneity will facilitate effective targeted therapy and find new ways to overcome the immunosuppression of tumor infiltrating immune cells (Chung et al. 2017).”
BackgroundZou, M., Zheng, Z., Xiahou, Z., & Cao, J. (2024) · Environmental Toxicology · doi:10.1002/tox.24189 · Cited by 1
“67,68 This technology has opened new windows into tumor biology, shedding light on aspects such as heterogeneity, evolution, metastasis, and the interactions between tumors and the immune sys-tem.”
RetractedLuo, Z., Liu, X., Chen, Y., Shen, L., Qin, H., Zha, Q., Hu, F., & Wang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28374 · Cited by 2
“In anti-angiogenesis therapy, the majority of agents have shown some evidence of activity, but increased toxicities have been observed, including an increased risk of death for some agents, limiting their development [9].”
BackgroundDefinition of a Multi-Omics Signature for Esophageal Adenocarcinoma Prognosis Prediction
Lambroia, L., Dioguardi, C. C., Puccio, S., Pansa, A., Alvisi, G., Basso, G., Cibella, J., Colombo, F., Marano, S., Basato, S., et al. (2024) · Cancers · doi:10.3390/cancers16152748 · Cited by 3
“…to reveal novel tissue heterogeneity that can improve patients’ stratification and guide personalized treatment decisions [4]: an example could be the TME and its transcription factors, already associated with tumor development and progression, response to treatment, or antitumor response [5–8].”
BackgroundLi, Z., Li, R., Gañán‐Gómez, I., Abbas, H. A., Colla, S., Garcia‐Manero, G., & Sun, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-75226-2 · Cited by 1
Arreza, L., Thanasupawat, T., Krishnan, S. N., Kraljevic, M., Klonisch, T. C., & Hombach‐Klonisch, S. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116624 · Cited by 2
Is the "PD-L1 macrophage score" possible as an immunotherapy target in colon adenocarcinoma?
Baş, Y. (2024) · Gastrointestinal Tumors · doi:10.48130/git-0024-0004 · Cited by 1
He, H., Yan, M., Ye, K., Shi, R., Tong, L., Zhang, S., Zhu, Y., & Zhan, R. (2025) · Cancer Reports · doi:10.1002/cnr2.70158 · Cited by 5
Gyanchandani, R., Priedigkeit, N., Basudan, A., & Lee, A. V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811785-9.00002-8 · Cited by 1
Single-Cell Transcriptome Analysis in Tumor Tissues
Iwabuchi, S., & Hashimoto, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84558 · Cited by 2
Gene Selection for scRNA-Seq Data Based on Information Gain and Fruit Fly Optimization Algorithm
Zhang, J., Feng, J., & Yang, X. (2019) · International Conference on Computational Intelligence and Security (CIS) · doi:10.1109/cis.2019.00047 · Cited by 1
Li, Y., DAI, L., Cai, K., Song, Y.-K., & LIU, X. (2021) · Biocell · doi:10.32604/biocell.2021.013612 · Cited by 1
Lee, A. C., Lee, H., Yeom, H., Song, S. W., Kim, S. D., Choi, A., Lee, S., Lee, Y., Han, W., & Kwon, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9620-6_11 · Cited by 2
Self-citationYuan, H., Yan, M., Liang, X., Liu, W., He, S., Sun, S., Zhang, X., & Lan, Y. (2022) · Oral Oncology · doi:10.1016/j.oraloncology.2022.106110 · Cited by 3
Estimation of Tumor Immune Signatures from Transcriptomics Data
Yu, X. (2022) · Springer handbooks of computational statistics · doi:10.1007/978-3-662-65902-1_16 · Cited by 2
Exploring and analysing immune single cell multi-omics data with VDJViewPreprint
Samir, J., Rizzetto, S., Gupta, M., & Luciani, F. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/613083 · Cited by 1
“SmartSeq2 breast cancer T and B cells, N = ~560 [11] 2.”
BackgroundMethodResultInfluentialSystemic sclerosis is a disease of a prematurely senescent, inflammatory and activated immunomePreprint
Paleja, B. S., Ling, A. L. H., Kumar, P., Saidin, S., Lajam, A. B. M., Hazirah, S. N., Chua, C. J. H., Yun, L. L., & Albani, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/637736 · Cited by 1
Bavli, D., Sun, X., Kozulin, C., Ennis, D., Motzik, A., Biran, A., Brielle, S., Alajem, A., Meshorer, E., Buxboim, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.24.395541 · Cited by 1
Single-cell analysis of localized low- and high-grade prostate cancersPreprint
Eksi, S. E., Chitsazan, A., Sayar, Z., THOMAS, G. V., Fields, A., Kopp, R. P., Spellman, P. T., & Adey, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.16.440238 · Cited by 1
“E. Lymphoid and myeloid immune cells and stromal cells were removed from the UMAP for downstream analyses.”
BackgroundInfluentialMarkerCount: A stable, count-based cell type identifier for single cell RNA-Seq experimentsPreprint
Kim, H., Lee, J., Kang, K., & Yoon, S. (2021) · Research Square · doi:10.21203/rs.3.rs-418249/v1 · Cited by 1
Self-citationMarkerCount: A stable, count-based cell type identifier for single cell RNA-Seq experimentsPreprint
Kim, H., Lee, J., Kang, K., & Yoon, S. (2021) · Research Square · doi:10.21203/rs.3.rs-418249/v2 · Cited by 1
Self-citationPolygenic risk scores associated with tumor immune infiltration in common cancersPreprint
Choi, J., Kim, J. S., Sung, H. J., Chen, Y., Chen, Z., Wen, W., Shu, X., & Guo, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1796640/v2 · Cited by 1
li, G. (2023) · Research Square · doi:10.21203/rs.3.rs-2812493/v1 · Cited by 1
Mocquery-Corre, M., Cartier, L., Aziz, A.-I., Berquand, A., Clachet, J., Jean, C. M., Raymond, A., Btaouri, H. E., Dupuy, J., Hachet, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.17.732906 · Cited by 1
Wen, X., Xu, W., Sun, X., Tu, J., & Lu, Z. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/338319
“The elaborately atlas of single cell, has shed light on multiple biological questions like revealing new cell types in cancers (Chung et al., 2017; Grün et al., 2015), investigating the dynamics of developmental processes (Li et al., 2017), linkage and developmental trajectory of immune cells in…”
BackgroundJia, D., Lu, M., Jung, K. H., Park, J. H., Yu, L., Onuchic, J. N., Kaipparettu, B. A., & Levine, H. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/428367
Gill, M. B., Koplev, S., Machel, A. C., & Miller, M. L. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/456855
The Landscape of Receptor-Mediated Precision Cancer Combination Therapy: A Single-Cell PerspectivePreprint
Ahmadi, S., Sukprasert, P., Vegesna, R., Sinha, S., Schischlik, F., Artzi, N., Khuller, S., Schäffer, A. A., & Ruppin, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.28.923532
Moorthy, A., & Quinn, S. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.03.186221
Kinker, G. S. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2020.tde-13022020-101209 · Cited by 1
Las armas de la villa de Pinto
Couto, F. G. (2005) · Anales del Instituto de Estudios Históricos del Sur de Madrid "Jiménez de Gregorio"
Yeo, S. K., Zhu, X., Okamoto, T., Hao, M., Lu, L. J., & Guan, J. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3316799
Djomehri, S. I. (2020) · Deep Blue (University of Michigan)
Jia, S. (2020) · Mspace (University of Manitoba)
A Link-Based Ensemble Cluster Approach for Identification of Cell Types
Lu, X., Gao, Y., Tang, D., & Yuan, Y. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-84529-2_54
Landscape of glioblastoma niches reveals the prognostic effects of tumor-infiltrating cellsPreprint
Xiao, Z., Zhang, W., Li, G., Li, W., Li, L., Sun, T., He, Y., Liu, G., Wang, L., Han, X., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.20.427411
“For scRNA-seq data, genes expressed in less than or equal to 10 cells were eliminated, followed by a moving average method [29] to determine chromosome expression patterns.”
MethodFerté, T., Villain, L., Thiébaut, R., & Hejblum, B. P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.07.459329
Cancer/Testis genes are predictive of breast tumor subtypesPreprint
Laisné, M., Benlamara, S., Nicolas, A., Djerroudi, L., Gupta, N., Daher, D., Ferry, L., Kirsh, O., Philippe, C., Okada, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.27.465656
“To verify that tumor cells themselves expressed HORMAD1 and CT83 (and not non-tumor cells of the microenvironment), we re-analyzed previously published single-cell RNA-seq data of 6 triple-negative breast tumors (of which 5 express HORMAD1 and CT83) (GSE75688, Chung et al. 2017).”
ResultIdentification of ATFs in Human Breast Cancer by Integrated Bioinformatic AnalysisPreprint
Geng, C., Pu, Q., Tian, S., Geng, W., Wang, H., Zhao, G., & Gao, H. (2021) · Research Square · doi:10.21203/rs.3.rs-948401/v1
Multiomics Analysis Reveals the Prognostic Non-tumor Cell Landscape in Glioblastoma Niches
Xiao, Z., Zhang, W., Li, G., Li, W., Li, L., Sun, T., He, Y., Liu, G., Wang, L., Han, X., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.741325
Expresión diferencial de los genes SERCA en células de cáncer de mama
Zarain‐Herzberg, Á., Izquierdo‐Torres, E., Hernández‐Oliveras, A., Rodríguez, G., & Lozano-Arriaga, D. (2021) · Gaceta Médica de México · doi:10.24875/gmm.20000614 · Cited by 7
Alvarado, Y. R. (1994) · Revista de derecho procesal
Alison (2012)
Diseño de una interfaz gráfica para la simulación mediante diferencias finitas
Martí, S. S.-P. (2014)
Herrera, E., & Escalante, A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736891319.793579545
Is it Time to Reconsider and Re-Stratergise B Lymphocyte Based Immunotherapy?
Smitha T, A. T. (2022) · Journal of Vaccines Immunology and Immunopathology · doi:10.29011/2575-789x.000166
Genomic and local microenvironment effects shaping epithelial-to-mesenchymal trajectories in cancerPreprint
Tagliazucchi, G. M., Wiecek, A. J., Withnell, E., & Secrier, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.23.453584
Single cell transcriptional profiling identifies heterogeneity in pleuropulmonary blastomaPreprint
Chen, Z. X., Zhang, W.-B., Ye, C. J., Zhan, Y., Yang, R., Liu, J., Li, Y., Hong, B., Wang, J., Tan, W.-Q., et al. (2020) · doi:10.22541/au.159129066.64155056
Polygenic risk scores associated with tumor immune infiltration in common cancersPreprint
Choi, J., Kim, J. S., Sung, H. J., Chen, Y., Chen, Z., Wen, W., Shu, X., Zheng, W., & Guo, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1796640/v1
Quantifying Cell-type-specific Differences of Single-cell Datasets using UMAP and SHAPPreprint
Lim, H. S., & Qiu, P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.15.500285
ATAXIC: An Algorithm to Quantify Transcriptomic Perturbation Heterogeneity in Single Cancer Cells
Liu, Q., Lu, Q., & Wang, X. (2022) · Journal of Oncology · doi:10.1155/2022/4106736
Serna, G., García, E., Fasani, R., Guardia, X., Pascual, T., Paré, L., Ruíz‐Pace, F., Llombart‐Cussac, A., Cortés, J., Prat, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.21.508826
Jin, B., Zhu, Z., & Ma, J. (2022) · Research Square · doi:10.21203/rs.3.rs-2188589/v1
张, 锦. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12111544
Updates of Role of Stem Cells in Cancer Therapy
Naser, M., Mn, M., & Shehata, L. H. (2022) · International Journal of Progressive Sciences and Technologies · doi:10.52155/ijpsat.v34.1.4557
Computational and Statistical Methods for Single-Cell RNA Sequencing Data
Wang, Z., & Yan, X. (2022) · Springer handbooks of computational statistics · doi:10.1007/978-3-662-65902-1_1
The application of RNA sequencing in precision cancer medicine
Saran, U., & Damodaran, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00026-5
Wu, G., Guo, W., Zhu, S., & Fan, G. (2023) · Journal of Oncology · doi:10.1155/2023/5355269 · Cited by 1
Singh, S., Sutcliffe, M. D., Repich, K., Atkins, K. A., Harvey, J. A., & Janes, K. A. (2023) · doi:10.1158/0008-5472.22429332
Chen, F., Ding, K., Priedigkeit, N., Elangovan, A., Levine, K. M., Carleton, N. M., Savariau, L., Atkinson, J. M., Oesterreich, S., & Lee, A. V. (2023) · doi:10.1158/0008-5472.c.6512673.v1
Zagorac, S., de Giorgio, A., Dabrowska, A., Kalisz, M., Casas-Vila, N., Cathcart, P. J., Yiu, A., Ottaviani, S., Degani, N., Lombardo, Y., et al. (2023) · doi:10.1158/0008-5472.c.6512499.v1
Singh, S., Sutcliffe, M. D., Repich, K., Atkins, K. A., Harvey, J. A., & Janes, K. A. (2023) · doi:10.1158/0008-5472.22429332.v1
Data from SOX9/FXYD3/Src Axis Is Critical for ER+ Breast Cancer Stem Cell Function
Xue, Y., Lai, L., Lian, W., Tu, X., Zhou, J., Dong, P., Su, D., Wang, X., Cao, X., Chen, Y., et al. (2023) · doi:10.1158/1541-7786.c.6541048
Morello, G., Cancila, V., Rosa, M. L., Germano, G., Lecis, D., Amodio, V., Zanardi, F., Iannelli, F., Greco, D., Paglia, L. L., et al. (2023) · doi:10.1158/2326-6066.c.6550167.v1
(2023) · Research Square · doi:10.21203/rs.3.rs-2812493/v2
Challenges for single-cell epigenetic analysis
Metzl-Raz, E., Kim, S. H., Zhang, C. R., & Greenleaf, W. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91367-6.00021-0
Self-citationNoh, S. U., Lim, J., Shin, S.-W., Kim, Y., Batinic̈‐Haberle, I., Choi, C., & Park, W. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4476691
Self-citationLei, J., Luo, J., Liu, Q., & Wang, X. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.05.547742
“This analysis revealed that the ratios of HSC/ESC signatures were higher in cancer cells of early-stage tumors than in those of late-stage tumors in BRCA (P = 0.05) (Fig.”
BackgroundMethodInfluentialCASi: A multi-timepoint scRNAseq data analysis frameworkPreprint
Wang, Y., Flowers, C. R., Wang, M. L., Huang, X., & Li, Z. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.16.553543
“of diseases, such as cancers [1, 2], Alzheimer’s disease [3, 4] and the SARS-CoV-2”
BackgroundLi, J., Chen, D., Zheng, Z., & Chen, J. (2023) · International Conference on Intelligent Computing and Signal Processing (ICSP) · doi:10.1109/icsp58490.2023.10248768
Attention Based Models for Cell Type Classification on Single-Cell RNA-Seq Data
Wang, T., Fan, Y., & Ma, X. (2023) · Frontiers in artificial intelligence and applications · doi:10.3233/faia230557
oncotree2vec – A method for embedding and clustering of tumor phylogenetic treesPreprint
Baciu-Drăgan, M.-A., & Beerenwinkel, N. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.16.567363
“Several methods to discover cancer subtypes and tumor clusters have been proposed, based on clustering data modalities individually [2, 8, 12], or using multi-omics integrative approaches [51, 1, 5].”
MethodShi, T., Yu, H., & Blair, R. H. (2023) · Statistical Applications in Genetics and Molecular Biology · doi:10.1515/sagmb-2022-0054
Snijesh, V. P., Nimbalkar, V. P., Patil, S., Rajarajan, S., Anupama, C. E., Mahalakshmi, S., Alexander, A., Ramu, S., Ramesh, R. S., Sri, B. S., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3829052/v1
Machine learning applications in cancer genomics
El-Charif, O., Schwartz, R. S., Yuan, Y., & Tao, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822000-9.00006-9
scFBApy: A Python Framework for Super-Network Flux Balance Analysis
Galuzzi, B. G., & Damiani, C. (2024) · Communications in computer and information science · doi:10.1007/978-3-031-57430-6_8
Yang, G., Peng, Q., Tian, Y., Xie, H., & Sun, B. (2024) · Research Square · doi:10.21203/rs.3.rs-4166156/v1
Zhang, Y., Zhang, D., Meng, Q., Liu, Z., Xie, H., Liu, L., Xu, F., & Chen, X. (2021) · Figshare · doi:10.6084/m9.figshare.15178652
Shi, A., Yan, M., Pang, B., Pang, L., Wang, Y., Lan, Y., Zhang, X., Xu, J., Ping, Y., & Hu, J. R. (2023) · Figshare · doi:10.6084/m9.figshare.24792276
Zhang, Y., Zhang, D., Meng, Q., Liu, Z., Xie, H., Liu, L., Xu, F., & Chen, X. (2021) · Figshare · doi:10.6084/m9.figshare.15178655
Zhang, Y., Zhang, D., Meng, Q., Liu, Z., Xie, H., Liu, L., Xu, F., & Chen, X. (2021) · Figshare · doi:10.6084/m9.figshare.15178661
Zou, G., Wang, J., Xu, X., Xu, P., Zhu, L., Yu, Q., Peng, Y., Guo, X., Li, T., & Zhang, X. (2021) · Figshare · doi:10.6084/m9.figshare.14684659
Zhang, Y., Zhang, D., Meng, Q., Liu, Z., Xie, H., Liu, L., Xu, F., & Chen, X. (2021) · Figshare · doi:10.6084/m9.figshare.15178664
Zou, Wang, J., Xu, X., Xu, P., Zhu, L., Yu, Q., Peng, Y., Guo, X., Li, T., & Zhang, X. (2021) · Figshare · doi:10.6084/m9.figshare.14684653
Zou, Wang, J., Xu, X., Xu, P., Zhu, L., Yu, Q., Peng, Y., Guo, X., Li, T., & Zhang, X. (2021) · Figshare · doi:10.6084/m9.figshare.14684644
Zou, Wang, J., Xu, X., Xu, P., Zhu, L., Yu, Q., Peng, Y., Guo, X., Li, T., & Zhang, X. (2021) · Figshare · doi:10.6084/m9.figshare.14684650
Zou, Wang, J., Xu, X., Xu, P., Zhu, L., Yu, Q., Peng, Y., Guo, X., Li, T., & Zhang, X. (2021) · Figshare · doi:10.6084/m9.figshare.14684629
Zou, Wang, J., Xu, X., Xu, P., Zhu, L., Yu, Q., Peng, Y., Guo, X., Li, T., & Zhang, X. (2021) · Figshare · doi:10.6084/m9.figshare.14684647
Zou, Wang, J., Xu, X., Xu, P., Zhu, L., Yu, Q., Peng, Y., Guo, X., Li, T., & Zhang, X. (2021) · Figshare · doi:10.6084/m9.figshare.14684641
Metadata
- Authors
- Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., Kan, Z., Han, W., & Park, W.-Y.
- Affiliations
- Samsung Medical Center (KR)
- Seoul National University (KR)
- Pfizer (United States) (US)
- Corresponding author
- Han, Wonshik
- Park, Woong-Yang
- ORCID
- Venue
- Nature Communications
- Published
- 2017-05-05
- Volume
- 8
- Issue
- 1
- Pages
- 15081-15081
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5424158
- OpenAlex
- W2610509384
- Cited by
- 992
- References
- 62
- Citations by year
- 2026: 57 · 2025: 85 · 2024: 116 · 2023: 117 · 2022: 148 · 2021: 191 · 2020: 106 · 2019: 93 · 2018: 63 · 2017: 11
- FWCI
- 30.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- National Research Foundation of Korea (2015R1A2A2A01008264, 2016R1A5A1011974)
- Samsung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, intratumoral heterogeneity, tumor immune microenvironment, tumor stroma, T cells, B cells, macrophages, regulatory T cells, T cell exhaustion, M2 macrophages, tumor subtypes, tumor transcriptome, copy number variation
- MeSH terms
- Exome Sequencing, B-Lymphocytes, Breast Neoplasms, Female, Humans, Lymph Nodes, Macrophages, Receptors, Estrogen, Receptors, Progesterone, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Sequence Analysis, RNA, Carcinoma, Ductal, Breast, Erb-b2 Receptor Tyrosine Kinases, Receptor, ErbB-2, Gene Expression Profiling, DNA Copy Number Variations, Single-Cell Analysis, Tumor Microenvironment, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.